Manifest and Concealed Accessory Pathways

How to Cite This Chapter: Acosta Velez JG, Amit G, Hernández Ruiz EA, Trusz-Gluza M, Leśniak W. Manifest and Concealed Accessory Pathways. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. Accessed July 07, 2020.
Last Updated: December 10, 2018
Last Reviewed: August 5, 2019
Chapter Information

Definition, Etiology, PathogenesisTop

Preexcitation syndromes refer to a form of congenital arrhythmias resulting from the presence of accessory pathways, that is, muscle fibers bypassing the physiologic conduction system and causing an early activation of a part of the ventricle. The most common type is Wolff-Parkinson-White (WPW) syndrome, which refers to the presence of an accessory pathway in association with supraventricular tachycardia (SVT).

Tachyarrhythmias observed in patients with WPW syndrome:

1) Orthodromic atrioventricular reentrant tachycardia (AVRT) (>85% of patients): A narrow-QRS tachycardia with anterograde conduction (from the atrium to the ventricle) over the atrioventricular (AV) node and retrograde conduction (from the ventricle to the atrium) over the accessory pathway.

2) Antidromic AV tachycardia: A wide-QRS tachycardia with anterograde conduction over the accessory pathway and retrograde conduction over the AV node or another accessory pathway.

3) Preexcited atrial fibrillation (AF): AF with rapid ventricular response, usually with varying degrees of preexcitation (different QRS widths). This may develop in patients with an accessory pathway capable of fast conduction.

Clinical Features and Natural HistoryTop

Symptoms (mainly palpitations) are seen in ~50% of patients with electrocardiographic (ECG) features of preexcitation and usually start during childhood; a new diagnosis of preexcitation in older individuals is rare. The presenting event may be ventricular fibrillation or sometimes syncope requiring hospital admission. Compared with healthy population, the risk of sudden cardiac death is increased particularly in symptomatic patients.


Diagnostic Tests

1. ECG:

1) Features of ventricular preexcitation during sinus rhythm: A shortened PR interval (<0.12 seconds) and a wide QRS with a delta wave in the first portion of the QRS. If preexcitation is not clear, one option is to repeat the ECG during IV administration of adenosine to block the AV node and reveal the accessory pathway (Figure 3.4-10).

2) ECG recorded during SVT:

a) Orthodromic AVRT: A regular narrow QRS, a retrograde P wave usually visible in the first portion of the ST segment (short-RP tachycardia).

b) Antidromic AVRT: A regular wide QRS of a fully preexcited morphology (morphology resembles preexcitation during sinus rhythm but QRS is wider).

c) Preexcited AF: An irregularly irregular rhythm with varying widths of QRS depending on the degree of preexcitation. At times there is a very rapid ventricular response.

2. Electrophysiologic study (EPS) is used to confirm the presence of an accessory pathway, establish the number and location of the pathways, assess their refractory periods, and to induce tachyarrhythmia to confirm the diagnosis.

Differential Diagnosis

SVT: see Figure 3.4-2. Narrow-QRS tachycardia: see Figure 3.4-3. Wide-QRS tachycardia: see Figure 3.4-4.

An abnormal QRS shape resulting from preexcitation may mimic myocardial infarction (MI), bundle branch blocks, or ventricular hypertrophy.


Acute Management

Termination of SVT:

1) Orthodromic (narrow-QRS) AVRT:

a) Same as for AVNRT (see Atrioventricular Nodal Reentrant Tachycardia).

b) Vagal maneuvers.

c) IV adenosine, diltiazem, verapamil, or beta-blockers can be used.

d) Synchronized cardioversion should be considered in hemodynamically unstable patients and in stable patients when pharmacologic therapy is ineffective or contraindicated.

e) IV ibutilide or IV procainamide is beneficial for acute treatment in patients with preexcited AF. If not available, IV amiodarone could be considered.

2) Antidromic (wide-QRS) AVRT: Administer antiarrhythmic drugs that act on the accessory pathway (eg, procainamide, amiodarone, flecainide, propafenone) or perform cardioversion. If preexcited AF has been excluded, a trial of adenosine or nodal blockers is an acceptable choice.

3) Preexcited AF: Adenosine and nodal blockers (calcium antagonists, beta-blockers) should not be used, as they may predispose to rapid ventricular rates and trigger ventricular fibrillation.

Long-Term Management

1. Patients with asymptomatic preexcitation:

1) EPS is reasonable to evaluate the risk for arrhythmic events. If the EPS identifies a high risk for arrhythmic events, catheter ablation is recommended.

2) The finding of abrupt loss of conduction over a manifest pathway during an exercise test or ambulatory monitoring is useful to identify patients at low risk of preexcited AF (the pathway would not be able to conduct at a very high heart rate during AF).

2. In patients with WPW syndrome causing symptomatic but well-tolerated arrhythmia, catheter ablation is considered first-line therapy, as it is highly effective and carries a low risk of complications. Medications are generally stopped after a successful procedure.

3. In patients with AVRT but without preexcitation on their resting ECG, oral beta-blockers, diltiazem, or verapamil are indicated for ongoing management. The confirmation of AVRT if preexcitation is not present on ECG during sinus rhythm can only be made with an EPS.

4. In patients with preexcitation and SVT who are not candidates for ablation, treat with flecainide or propafenone to block conduction through the accessory pathway. If not available or contraindicated, amiodarone or sotalol may also be considered.

5. In patients with WPW syndrome causing AF with fast conduction or poorly tolerated AVRT, catheter ablation is highly recommended.


Figure 3.4-10. Preexcitation syndrome: short PR interval, delta wave on the ascending arm of the R wave (arrow), ST segment and T wave discordant with the QRS complex.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.